He will discuss the NHS with the Finance and Health Ministers The implementation of the National Health System (NHS), as well as Cypriot patients’ access to innovative medicines, will be discussed during separate meetings between the Director General of the European...
Pharmaceutical companies will disclose expenses covered for healthcare professionals with the aim of boosting transparency The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) takes press coverage on the World Health Organisation’s (WHO)...
NHS and patients’ access to innovative medicines of top priority Kyriakos Mikellis, Cyprus Business Manger at Pfizer, has been elected as the new President of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) for the next two years....
*Joanna Kozakou In recent years there has been a growing interest in the nature of the pharmaceutical industry’s relationships with healthcare professionals and healthcare organizations, particularly because patients and the public at large want to be sure that...
Στη δημοσιότητα θα δίνονται οι καλύψεις εξόδων στις οποίες προβαίνουν οι φαρμακευτικές εταιρείες προς τους επαγγελματίες υγείας, στο πλαίσιο πανευρωπαϊκής πρωτοβουλίας για αυστηρότερο πλαίσιο αυτορρύθμισης του κλάδου και ενίσχυση της διαφάνειας. Λεπτομέρειες σχετικά...
